Dimensional Fund Advisors LP Sells 602,044 Shares of Procter & Gamble Company (The) $PG

Dimensional Fund Advisors LP reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 5.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,877,702 shares of the company’s stock after selling 602,044 shares during the period. Procter & Gamble accounts for approximately 0.4% of Dimensional Fund Advisors LP’s holdings, making the stock its 26th largest holding. Dimensional Fund Advisors LP’s holdings in Procter & Gamble were worth $1,671,347,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in PG. Great Lakes Retirement Inc. boosted its holdings in Procter & Gamble by 11.0% during the third quarter. Great Lakes Retirement Inc. now owns 21,276 shares of the company’s stock worth $3,269,000 after buying an additional 2,106 shares during the last quarter. Griffith & Werner Inc. acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at approximately $4,026,000. USAdvisors Wealth Management LLC boosted its stake in Procter & Gamble by 8.2% during the 3rd quarter. USAdvisors Wealth Management LLC now owns 3,957 shares of the company’s stock worth $608,000 after acquiring an additional 301 shares during the last quarter. South Dakota Investment Council grew its holdings in Procter & Gamble by 7.0% during the third quarter. South Dakota Investment Council now owns 45,579 shares of the company’s stock valued at $7,003,000 after purchasing an additional 3,000 shares during the period. Finally, Level Four Advisory Services LLC increased its stake in Procter & Gamble by 1.4% in the third quarter. Level Four Advisory Services LLC now owns 47,872 shares of the company’s stock valued at $7,356,000 after purchasing an additional 661 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Insiders Place Their Bets

In other news, Chairman Jon R. Moeller sold 162,232 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.45, for a total value of $26,354,588.40. Following the completion of the transaction, the chairman owned 319,385 shares in the company, valued at $51,884,093.25. This trade represents a 33.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,827 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total value of $2,056,296.37. Following the sale, the insider owned 12,639 shares in the company, valued at $2,026,158.09. The trade was a 50.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 348,618 shares of company stock valued at $55,462,643 in the last quarter. Company insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on PG shares. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, December 29th. JPMorgan Chase & Co. raised Procter & Gamble from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $157.00 to $165.00 in a research note on Friday, January 23rd. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and increased their price target for the stock from $156.00 to $179.00 in a report on Tuesday, December 16th. Rothschild & Co Redburn lifted their price objective on Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a report on Friday, January 23rd. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Tuesday, February 17th. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $168.33.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $159.68 on Wednesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. The firm has a market cap of $371.10 billion, a price-to-earnings ratio of 23.66, a price-to-earnings-growth ratio of 5.46 and a beta of 0.37. The stock’s 50-day moving average is $151.70 and its 200-day moving average is $151.16. Procter & Gamble Company has a one year low of $137.62 and a one year high of $179.99.

Procter & Gamble (NYSE:PG) last announced its earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The business had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.Procter & Gamble’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were issued a dividend of $1.0568 per share. The ex-dividend date was Friday, January 23rd. This represents a $4.23 annualized dividend and a yield of 2.6%. Procter & Gamble’s dividend payout ratio is presently 62.67%.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G announced a major shareholder‑return program (~$10 billion) that reinforces its income profile and supports dividend‑oriented holders. This is a clear long‑term positive for valuation and yield investors. Read More.
• Positive Sentiment: Q4: EPS slightly beat estimates and management provided FY2026 EPS guidance (6.830–7.090) roughly in line with expectations — evidence of earnings resilience even as revenue missed marginally. That supports the stock’s defensive, cash‑flow narrative. Read More.
• Positive Sentiment: Management is pitching an AI/technology shift (AI‑driven product development, supply‑chain automation) as a growth lever presented at CAGNY — a strategic message that can boost margins over time if execution follows. Read More.
• Neutral Sentiment: P&G’s brand and product initiatives (Gain Plus launch; Spruce marketing/mascot) support long‑term brand health but are unlikely to move shares materially in the near term. Read More. Read More.
• Neutral Sentiment: Analyst coverage remains broadly constructive (average rating: Moderate Buy; mixed price targets), and large institutional holders have been adding to positions — both stabilize the investor base but don’t explain intraday moves. Read More.
• Negative Sentiment: Insider selling: CEO Ma. Fatima Francisco sold 5,549 shares (about $917k) and reduced her stake materially — a disclosure that often triggers short‑term selling or investor caution even if for personal reasons. Read More.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.